explore -WSS

explore

author：comprehensive 2025-09-06 04:13:11 - browse：11

An eye emerges from lines of binary codes — health tech coverage from STAT — Adobe

Investors are starting to back startups that offer privacy and security services to bolster health AI products already on the market while they wait for crucial safety and privacy regulations to take shape.

Though health leaders are racing to deploy generative AI products that can automatically transcribe doctor-patient conversations during medical appointments or churn through massive repositories of scientific research, they’re still flummoxed about how to measure their quality. Cybersecurity experts have warned that indiscriminately hooking third-party apps up to health system networks could expose sensitive data to hackers as ransomware attacks surge, and regulators and industry groups are rushing to set standards for responsible AI use.

Several government agencies and industry groups are working on rules and recommendations for avoiding bias and safety hazards within medical AI, but hospitals and startups are still in the dark about what exactly those will require and who’ll eventually be liable for any harm caused. It could be months, or even years, before these overlapping rules from multiple federal agencies are in place, and those rules might still change as the technology evolves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： AI models in health care face new federal disclosure requirements

WSS

Virtual Event: March of the Biosimilars

Supreme Court wrestles with OxyContin maker's bankruptcy deal

5 to watch: Tech startups trying to solve health care's staffing crisis

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Pharma patents targeted by Biden in move to slash drug prices

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

focus

explore

entertainment

Heart attack and stroke risk calculators need revising

Readout Newsletter: Bluebird, CVS, Contineum

In age of alternative facts, a scholarly course on calling out crap

SCOTUS to consider access to abortion pill mifepristone

At least 13 dead in Texas as scorching temps continue

Gene editing the human germline: What are the risks?

Medicare details structure of new drug price negotiation program

Congenital heart disease patients face new threat of heart failure

Psychedelics group wrestles with new pharma identity

Virtual Event: March of the Biosimilars

hotspot

Chemotherapy shortages won’t get better under Biden’s latest plan

What causes an itch? Researchers may have solved the mystery

CVS Caremark has created a new ploy: the drug ‘rebate credit’

In diabetes hearing, Sanders takes on a new foe: food makers

FDA needs staff influx to meet gene therapy needs, Marks says

Positive childhood experiences can help future health

hotspot

leisure time

focus

hotspot